JPMORGAN CHASE & CO - SYNERON MEDICAL LTD ownership

SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 4 filers reported holding SYNERON MEDICAL LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 23.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SYNERON MEDICAL LTD
ValueSharesWeighting
Q2 2017$182,000
+287.2%
16,601
+199.7%
0.00%
Q4 2016$47,000
-47.2%
5,540
-55.5%
0.00%
Q3 2016$89,000
-99.6%
12,463
-99.5%
0.00%
-100.0%
Q2 2016$20,202,000
+3.7%
2,626,982
-1.4%
0.01%0.0%
Q1 2016$19,482,000
-11.0%
2,665,153
-6.1%
0.01%0.0%
Q4 2015$21,889,000
+8.9%
2,839,121
+1.0%
0.01%0.0%
Q3 2015$20,094,000
-35.2%
2,810,370
-3.8%
0.01%
-28.6%
Q2 2015$31,022,000
-13.6%
2,921,000
+0.8%
0.01%
-12.5%
Q1 2015$35,888,000
+85.2%
2,898,899
+39.6%
0.01%
+100.0%
Q4 2014$19,375,000
-14.3%
2,076,654
-8.0%
0.00%
-20.0%
Q3 2014$22,615,000
-4.0%
2,256,927
-1.1%
0.01%
-16.7%
Q2 2014$23,549,000
-22.7%
2,281,801
-6.7%
0.01%
-25.0%
Q1 2014$30,458,000
+3.1%
2,446,396
+1.9%
0.01%0.0%
Q4 2013$29,529,000
+42.4%
2,400,657
-0.2%
0.01%
+33.3%
Q3 2013$20,731,000
-1.0%
2,404,977
-0.0%
0.01%
-14.3%
Q2 2013$20,933,0002,406,0770.01%
Other shareholders
SYNERON MEDICAL LTD shareholders Q3 2017
NameSharesValueWeighting ↓
Senvest Management, LLC 2,988,261$25,759,0002.86%
NORTH TIDE CAPITAL, LLC 2,150,000$18,533,0001.94%
HOURGLASS CAPITAL, LLC 838,900$7,231,0001.26%
Baupost Group 4,000,000$34,480,0000.98%
DAFNA Capital Management LLC 90,947$784,0000.86%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 573,108$4,940,0000.77%
Visium Asset Management, LP 3,405,000$29,351,0000.67%
PERRITT CAPITAL MANAGEMENT INC 380,000$3,276,0000.64%
Leonard Capital Management, Inc. 112,109$966,0000.38%
BRANDES INVESTMENT PARTNERS, LP 1,765,018$15,214,0000.20%
View complete list of SYNERON MEDICAL LTD shareholders